The biggest names in cardiac care gathered in San Diego for the Heart Rhythm Society (HRS) 2025 Annual Meeting. Topics ranged from pulsed field ablation (PFA) to insertable cardiac monitors, with AI and other technologies also generating interest. All of the data shared at HRS 2024 demonstrated the never-ending innovation in cardiac care, while also […]
Abbott
Abbott has positive study results for Aveir CSP leadless pacemaker
Abbott today announced data from an acute clinical feasibility study of its Aveir Conduction System Pacing (CSP) system. It marks the world’s first assessment of a leadless pacemaker delivering conduction pacing to the heart’s left bundle branch (LBB) area, Abbott says. CSP targets the LBB area by enabling pacing that mimics the heart’s natural electric […]
New data supports Abbott Volt pulsed field ablation system
Abbott today announced new study data demonstrating the safety and efficacy of its Volt pulsed field ablation (PFA) system. The Volt CE Mark study evaluated Volt’s safety and efficacy out to 12 months for treating AFib. Data highlighted the system’s safety profile along with its ability to achieve results with fewer therapy applications (4.7 applications […]
FDA says recall of Abbott HeartMate power unit is serious
The FDA issued a notice deeming a recall of the Abbott HeartMate Mobile Power Unit (MPU) as the most serious type. Abbott’s MPU is an accessory of its HeartMate II and HeartMate 3 left ventricular assist device (LVAD) systems. These systems feature an implantable pump diverting blood from the weakened left ventricle of the heart, […]
Medtronic submits interoperable insulin pump to FDA to advance collaboration with Abbott
Medtronic today announced a significant milestone in its landmark diabetes collaboration with Abbott . Our sister site, Drug Delivery Business News, reports today that Medtronic submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin pump. Clearance would enable system integration with a continuous glucose monitor (CGM) sensor based on Abbott’s most advanced platform. […]
Abbott launches universal FreeStyle Libre CGM app in U.S.
Abbott has launched a new Libre smartphone app for users of its popular FreeStyle Libre CGMs. Our sibling Drug Delivery Business News site reports that the new app works with both its FreeStyle Libre 2 and FreeStyle Libre 3 continuous glucose monitoring systems. “By listening to our customers, we developed a universal app with enhanced […]
Abbott sticks by its full-year guidance amid trade war
Abbott today reported first quarter results that beat the Wall Street analyst consensus on earnings but missed on revenue. The Abbott Park, Illinois–based developer of medtech, diagnostics, and more stuck by its 2025 guidance amid economic turmoil from the Trump administration’s unpredictable global trade moves. Company leaders highlighted the company’s diverse business model, saying it […]
Abbott bolsters its Heart Failure leadership
A leader in the Abbott Heart Failure division announced on social media that the company named Dr. Finn Gustafsson as the unit’s chief medical officer. Katie Spayde, Abbott VP and president of the company’s Heart Failure business, shared the news of Gustafsson’s appointment on LinkedIn. He succeeds Dr. Philip Adamson, who left for the same […]
Medtech stocks sink in trade war
The past week has been tough on the stocks of major medtech companies, which, like many, are figuring out how to manage the Trump administration’s new global trade war. The S&P 500 briefly entered bear market territory today as it swung wildly in response to chaotic news reports about what the administration and other countries […]
Abbott launches next-gen delivery system for Proclaim DRG neurostim
Abbott announced today that it launched a next-generation delivery system for its neuromodulation business. The medtech giant plans to use this system to streamline implantation for electrodes use with its Proclaim DRG neurostimulation system. It designed its new system to streamline the procedure when doctors implant them in patients suffering from complex regional pain syndrome […]
The biggest cardiology tech news out of ACC 2025
Chicago was the site for the latest edition of the American College of Cardiology (ACC) Scientific Sessions. There, a number of the biggest names in heart technology shared clinical findings highlighting the latest innovations in the space. Study data highlighted the benefits of technologies including replacement heart valves, monitors and more. Companies like Medtronic, Edwards, […]
